Frontiers in Nutrition (Jun 2024)

Associations of life’s essential 8 with MAFLD and liver fibrosis among US adults: a nationwide cross-section study

  • Depeng Liang,
  • Depeng Liang,
  • Depeng Liang,
  • Jie Zhang,
  • Jie Zhang,
  • Jie Zhang,
  • Lu Li,
  • Lu Li,
  • Lu Li,
  • Yonggang Li,
  • Yonggang Li,
  • Yonggang Li,
  • Lidong Xu,
  • Lidong Xu,
  • Lidong Xu,
  • Huili Wu,
  • Huili Wu,
  • Huili Wu

DOI
https://doi.org/10.3389/fnut.2024.1403720
Journal volume & issue
Vol. 11

Abstract

Read online

BackgroundLife’s essential’ 8 (LE8) is a newly updated cardiovascular health (CVH) metrics from the American Heart Association, with close relevance to metabolism. Our objective is to explore the association between LE8 scores and incidence of metabolic dysfunction-associated fatty liver disease (MAFLD) and advanced liver fibrosis in American adults.MethodsThis population-based cross-sectional study utilized data from the National Health and Nutrition Examination Survey (NHANES) conducted between 2005 and 2018, encompassing adults aged 20 years or older. Validated non-invasive scoring systems were employed to define liver steatosis and advanced liver fibrosis. Multivariable logistic regression and smooth curve fitting techniques were applied to evaluate the associations. All analyses were adjusted for the survey’ complex design parameters and accounted for sample weights.ResultsA total of 11,820 participants were included. A higher LE8 score was found to be inversely associated with the incidence of MAFLD and advanced liver fibrosis, with odds ratios (OR) of 0.64 (95% CI: 0.57–0.71) for MAFLD and 0.75 (95% CI: 0.61–0.92) for advanced liver fibrosis per 1 standard deviation (SD) increase in LE8 score. Similar patterns were found in the relationship between health behaviors/factors score and incidence of MAFLD and advanced liver fibrosis. In subgroup analyses, the interaction test showed that age, education level, marital status, CVD, hypertension and diabetes had a significant impact on the association between LE8 score and MAFLD (all P for interaction < 0.05). Among male, elderly, wealthy, other race, CVD, diabetes and depression participants, the correlation between LE8 score and advanced liver fibrosis was not statistically significant (P > 0.05). Younger participants exhibited a more pronounced negative association between the CVH metric and both MAFLD and advanced life fibrosis.ConclusionLE8 and its subscales score were inversely associated with the presence of MAFLD and advanced liver fibrosis in non-linear patterns. Optimal LE8 score may significantly reduce the risk of liver steatosis and fibrosis.

Keywords